Vice President (Investments) at EDB Investments
Thong-Yuen is a Vice President (investments) of EDB Investments (EDBI), the corporate venture arm of the Singapore Economic Development Board. He is currently part of the Life-sciences Group. Previously, he was Head of the EDBI Boston Center and managed the investment opportunities in the East Coast of North America for (i) life-sciences, (ii) cleantech and (iii) internet and digital media.
Thong Yuen has more than 10 years of experience in investments and research. He joined EDBI in 2004, and has been involved in various therapeutics, medtech and CRO investments. Main geographical areas covered include USA and Japan. In addition to Ivantis, other notable biomedical sciences investments that Thong Yuen is involved in include Amaranth Medical, Forma Therapeutics, Inviragen (acquired by Takeda Pharmaceutical) and Artisan Pharma (acquired by Asahi Kasei Pharma). His previous research experience includes computer-aided drug design, medicinal chemistry, radio-ligand binding assays and animal studies. Thong Yuen also has a good background in community pharmacy and pharmaceutical manufacturing processes. He earned his doctorate in Medicinal Chemistry and honours degree in Pharmacy from the National University of Singapore.